Blood Screening Market By Product Type (Reagents & Kits, Instruments, Software), By Technology (Nucleic Acid Testing (NAT), ELISA, Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)), By Application (Infectious Disease Detection, Blood Group Typing, Cancer Detection, Metabolic Disorders, Drug Testing, Others), By End-user (Blood Banks, Hospitals, Clinical Laboratories, Plasma Donation Centers, Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Reagents & Kits
• Instruments
• Software

By Technology

• Nucleic Acid Testing (NAT)
• ELISA
• Rapid Tests
• Western Blot Assays
• Next-Generation Sequencing (NGS)

By Application

• Infectious Disease Detection
• Blood Group Typing
• Cancer Detection
• Metabolic Disorders
• Drug Testing
• Others

By End User

• Blood Banks
• Hospitals
• Clinical Laboratories
• Plasma Donation Centers
• Academic & Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Grifols, S.A.
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Ortho Clinical Diagnostics Holdings plc
• Becton, Dickinson and Company
• QuidelOrtho Corporation
• PerkinElmer, Inc.
• Diasorin S.p.A.
• Merck KGaA
• Beckman Coulter, Inc.